Related Experiment Video
Updated: Jan 9, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Progress in the Mechanism of Hyperhomocysteinemia-Induced Renal Injury
Insights
High homocysteine (Hcy) levels independently increase cardiovascular disease risk. This study details how hyperhomocysteinemia accelerates chronic kidney disease progression through multiple complex mechanisms.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Homocysteine (Hcy), a methionine metabolism byproduct, is a known cardiovascular disease risk factor.
- The link between hyperhomocysteinemia and renal disease is increasingly recognized.
- Mechanisms of Hcy's role in cardiovascular pathology within chronic kidney disease (CKD) are complex.
Purpose of the Study:
- To summarize the multifaceted mechanisms by which hyperhomocysteinemia contributes to renal injury.
- To elucidate the pathways involved in Hcy-induced cardiovascular and renal pathology in CKD patients.
Main Methods:
- Comprehensive literature review and synthesis.
- Analysis of existing research on hyperhomocysteinemia and kidney disease.
Main Results:
- Hyperhomocysteinemia induces renal injury via oxidative stress, endothelial damage, inflammation, autophagy, apoptosis, fibrosis, and epigenetic changes.
- These pathways synergistically contribute to glomerulosclerosis, tubular atrophy, and interstitial fibrosis.
- Multiple interrelated mechanisms accelerate renal failure in hyperhomocysteinemic individuals.
Conclusions:
- Hyperhomocysteinemia exacerbates renal damage through a complex interplay of pathways.
- Targeting these multiple mechanisms may be crucial for comprehensive intervention strategies.
- Effective management of hyperhomocysteinemia is vital for slowing CKD progression and preventing renal failure.
Background:
Hcy is a sulfhydryl amino acid in the metabolism of methionine. It has been recognized as an independent risk factor for cardiovascular disease. In recent years, the relationship between hyperhomocysteinemia and renal disease has received attention from many researchers. However, the specific mechanisms by which Hcy plays a role in cardiovascular pathology in patients with chronic kidney disease are complex.
Methods:
We consulted the relevant literature and sorted and summarized it.
Results:
Multiple mechanisms of hyperhomocysteinemia-induced renal injury are summarized in detail from different perspectives, including oxidative stress, vascular endothelial damage, inflammatory response, cellular autophagy, apoptosis, fibrosis, and epigenetic regulation.
Conclusions:
Hyperhomocysteinemia acts synergistically through multiple pathways, leading to glomerulosclerosis, tubular atrophy, and interstitial fibrosis, and ultimately accelerating renal failure. These mechanisms are complex and interrelated, suggesting that a comprehensive intervention strategy may achieve the ultimate goal of reducing renal injury.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction

